vial_table
TL2 Member · Zürich, CH
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 17 November 2024 · last posted 7d · groups: translators
78Posts here
2Topics
1Solutions
162Likes received
122Likes given
18Badges
75Days visited
1.1kPosts read
Stated areas
Recent activity
Full stream-
Follow-up: External review after an internal denial Replied, post #10 · Access › Insurance & coverage · 21 Jul 2026 · 9 likes Worth separating two things that post #6 runs together. A well-written denial is genuinely useful because it tells you exactly what to submit next. A vague one is the…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #124 · Evidence › Journal club · 21 Jul 2026 · 8 likes Post #120 describes the usual case. This is about the unusual one. The figures usually contain the finding and the text usually contains the interpretation. Separating…
-
Coming back to: Telehealth prescribing models in the US Replied, post #18 · Regional › North America · 17 Jul 2026 · 5 likes I would be cautious about generalising from the Telehealth prescribing models example above. It is a good example. It is one example.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #40 · Documentation › Doc review · 11 Jul 2026 · 3 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. Fact-checking: if you see a factual claim in a maintained page that you have…
-
What a reversed-phase purity number actually is Replied, post #24 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 10 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. Injection volume matters because column overload distorts peak…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #51 · Practice › Administration · 3 Jul 2026 · 0 likes Post #49 and I disagree about the size of the effect, not about the direction. A new needle for each injection is not fussiness. A needle blunts on first use and a…
-
Athletes in weight-category sports: a different risk calculus Replied, post #11 · Clinical › Special populations · 3 Jul 2026 · 16 likes Athletes in weight-category sports: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and…
-
What changed in 2026, by region — does this still hold? Replied, post #17 · Access › International · 22 Jun 2026 · 14 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #51 · Compounds › Oral incretins · 20 Jun 2026 · 9 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Request: a per-category review queue Replied, post #46 · Meta › Feature requests · 19 Jun 2026 · 27 likes That is clearer than the version I had in my head. Thank you.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #39 · Analytics › HPLC & UHPLC · 16 Jun 2026 · 0 likes Checked the Carryover claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #106 · Access › Insurance & coverage · 16 Jun 2026 · 0 likes Post #105 describes the usual case. This is about the unusual one. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…